Hopes for a last-minute deal to avoid a government shutdown are fading, raising the prospect of delays to crucial economic data as the Federal Reserve considers its next interest-rate move. Stocks ...

President Trump on Tuesday announced a deal with Pfizer to sell its drugs directly to consumers at discounted prices. They'll be available through a website operated by the federal government called ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Drugmaker Pfizer has agreed to lower drug costs ...

SYDNEY, Oct 1 (Reuters) - Australian home prices increased at the fastest pace in a year in September, driven by rate cuts and record-low listings, property consultant Cotality said on Wednesday.

The administration is also working on setting up a website they plan to call TrumpRX that would allow people to buy drugs directly from manufacturers. Drugmaker Pfizer has agreed to lower drug costs ...

President Donald Trump on Tuesday announced a multipronged effort aimed at lowering drug costs in the United States, including the creation of a “TrumpRx” direct-to-consumer website where Americans ...

The White House has been pursuing efforts to lower U.S. drug costs by linking them to the cheaper prices paid abroad. President Donald Trump on Sept. 30 announced that pharmaceutical giant Pfizer ...

Mats Zuccarello will miss the start of the regular season for the Minnesota Wild because of a lower-body injury. The 38-year-old forward is expected to miss a minimum of 7-8 weeks. Wild general ...

J.T. Miller did not practice Tuesday, one day after the New York Rangers forward sustained a lower-body injury. The forward and new Rangers captain is day to day. Miller was injured Monday while ...

The White House is planning to launch a new direct-to-consumer website, dubbed TrumpRx, that would allow Americans to buy certain prescription drugs at discounted prices negotiated by the government.

Abstract: Predicting protein-ligand binding affinities is a critical problem in drug discovery and design. A majority of existing methods fail to accurately characterize and exploit the geometrically ...

Multinational taxpayers are facing a growing compliance burden, say Vrajesh Dutia and Gregoire de Vogüé of Deloitte, as they highlight notable transfer pricing rulings concerning ranges, intragroup ...